HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial

Peer Review reports

Original Submission
18 Jul 2023	Submitted	Original manuscript
2 Oct 2023	Reviewed	Reviewer Report - Gowrie Balasubramaniam
19 Oct 2023	Reviewed	Reviewer Report - Rohan Anand
20 Nov 2023	Author responded	Author comments - Thomas Bais
Resubmission - Version 2
20 Nov 2023	Submitted	Manuscript version 2
8 Dec 2023	Reviewed	Reviewer Report - Gowrie Balasubramaniam
18 Dec 2023	Reviewed	Reviewer Report - Rohan Anand
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
24 Jan 2024	Editorially accepted
14 Feb 2024	Article published	10.1186/s13063-024-07952-x

Back to article page